Der Gastrointestinaltrakt in der Intensivmedizin – Übersicht 2020

Erkrankungen des Gastrointestinaltrakts sind als primäre und noch häufiger als sekundäre Diagnosen in der Intensivmedizin anzutreffen. Im Rahmen der vorliegenden Übersicht werden die Pathogenese, Diagnostik und Therapie von 3 sehr relevanten aktuellen Themen vorgestellt: Prophylaxe und Management der gastrointestinalen Blutung, gastrointestinale Motilitäts- und Resorptionsstörungen und Leberfunktionsstörungen in der Intensivmedizin.

Abstract

Gastrointestinal dysfunctions and failure are common clinical incidents in critically ill patients, which are recognized as both, primary and even more often as secondary diagnoses as consequence of an already existing disease or as a corollary of intensive care treatment. These functional complications may aggravate into life-threatening emergencies and are highly associated with prognosis and increased mortality.

This article gives an overview about the pathophysiology, diagnostics and therapy of three very relevant current topics in intensive care medicine: prophylaxis and management of gastrointestinal bleeding, gastrointestinal motility and absorption disorders as well as different forms of liver dysfunctions.

Schlüsselwörter

gastrotintestinale Blutung - Motilitätsstörung - Leberfunktion

Key words

gastrointestinal bleeding - motility disorder - liver function

Publication History

Article published online:
17 November 2020

• Literatur

• 1 Krag M, Marker S, Perner A. et al Pantoprazole in Patients at Risk for Gastrointestinal Bleeding in the ICU. N Engl J Med 2018; 379: 2199-2208 . doi:10.1056/NEJMoa1714919
• 2 Barbateskovic M, Marker S, Granholm A. et al Stress ulcer prophylaxis with proton pump inhibitors or histamin-2 receptor antagonists in adult intensive care patients. Intens Care Med 2019; 45: 143-158 . doi:10.1007/s00134-019-05526-z
• 3 Bardou M, Quenot JP, Barkun A. Stress-related mucosal disease in the critically ill patient. Nat Rev Gastroenterol Hepatol 2015; 12: 98-107 . doi:10.1038/nrgastro.2014.235
• 4 Rhodes A, Evans LE, Alhazzani W. et al Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intens Care Med 2017; 43: 304-377 . doi:10.1007/s00134-017-4683-6
• 5 Götz M, Anders M, Biecker E. et al [S2k Guideline Gastrointestinal Bleeding – Guideline of the German Society of Gastroenterology DGVS]. Z Gastroenterol 2017; 55: 883-936 . doi:10.1055/s-0043-116856
• 6 Lau JYW, Yu Y, Tang RSY. et al Timing of Endoscopy for Acute Upper Gastrointestinal Bleeding. N Engl J Med 2020; 382: 1299-1308 . doi:10.1056/NEJMoa1912484
• 7 Albert JG, Peiffer KH. [New methods for endoscopic hemostasis: focus on non-variceal gastrointestinal bleeding]. Z Gastroenterol 2016; 54: 250-255 . doi:10.1055/s-0035-1566987
• 8 Kuellmer A, Behn J, Meier B. et al Over-the-scope clips are cost-effective in recurrent peptic ulcer bleeding. Unit Eur Gastroenterol J 2019; 7: 1226-1233 . doi:10.1177/2050640619871754
• 9 Lv Y, Yang Z, Liu L. et al Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis. Lancet Gastroenterol Hepatol 2019; 4: 587-598 . doi:10.1016/S2468-1253(19)30090-1
• 10 Oakland K, Chadwick G, East JE. et al Diagnosis and management of acute lower gastrointestinal bleeding: guidelines from the British Society of Gastroenterology. Gut 2019; 68: 776-789 . doi:10.1136/gutjnl-2018-317807
• 11 Reintam Blaser A, Poeze M, Malbrain ML. et al Gastrointestinal symptoms during the first week of intensive care are associated with poor outcome: a prospective multicentre study. Intens Care Med 2013; 39: 899-909 . doi:10.1007/s00134-013-2831-1
• 12 Otani S, Coopersmith CM. Gut integrity in critical illness. J Intens Care 2019; 7: 17 . doi:10.1186/s40560-019-0372-6
• 13 Geer RJ, Richards WO, O'Dorisio TM. et al Efficacy of octreotide acetate in treatment of severe postgastrectomy dumping syndrome. Ann Surg 1990; 212: 678-687 . doi:10.1097/00000658-199012000-00005
• 14 Andresen V, Enck P, Frieling T. et al S2k-Leitlinie Chronische Obstipation: Definition, Pathophysiologie, Diagnostik und Therapie. Stand 02/2013. AWMF-Register Nr 021/019
• 15 Thomas J, Karver S, Cooney GA. et al Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med 2008; 358: 2332-2343 . doi:10.1056/NEJMoa0707377
• 16 Gudsoorkar V, Quigley EMM. Choosing a Prokinetic for Your Patient Beyond Metoclopramide. Am J Gastroenterol 2020; 115: 5-8 . doi:10.14309/ajg.0000000000000463
• 17 Keller J. Medikamentöse Therapie bei Motilitätsstörungen von Ösophagus und Magen. Arzneiverordnung in der Praxis 2016; 43: 4-14
• 18 Chakaroun RM, Massier L, Kovacs P. Gut Microbiome, Intestinal Permeability, and Tissue Bacteria in Metabolic Disease: Perpetrators or Bystanders?. Nutrients 2020; 12: 1082 . doi:10.3390/nu12041082
• 19 MacLeod JB, Lefton J, Houghton D. et al Prospective randomized control trial of intermittent versus continuous gastric feeds for critically ill trauma patients. J Trauma 2007; 63: 57-61 . doi:10.1097/01.ta.0000249294.58703.11
• 20 Koch A, Bundgens L, Tacke F. Nutrition Support Therapy in Critically Ill Patients. Dtsch Med Wochenschr 2019; 144: 897-909 . doi:10.1055/a-0665-6749
• 21 Strnad P, Tacke F, Koch A. et al Liver – guardian, modifier and target of sepsis. Nat Rev Gastroenterol Hepatol 2017; 14: 55-66 . doi:10.1038/nrgastro.2016.168
• 22 Leonhardt S, Veltzke-Schlieker W, Adler A. et al Trigger mechanisms of secondary sclerosing cholangitis in critically ill patients. Crit Care 2015; 19: 131 . doi:10.1186/s13054-015-0861-5
• 23 Andresen V, Wedel T. Opioidinduzierte Obstipation. Arzneiverordnung in der Praxis 2016; 43: 21-29